DATATRAK Announces Expanded DATATRAK ONE™ Product Suite
Are you ready for the 'u'?
CLEVELAND, June 20, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the expansion and rebranding of their unified software suite as DATATRAK ONE™. The unified software suite consists of seven products – all of which are being demonstrated at the 2011 DIA National Meeting.
DATATRAK ONE™ provides an end-to-end clinical enterprise solution by empowering clinical users and service providers with the components necessary for efficiently designing, delivering and managing their clinical trials. Being the only patented, unified solution differentiates DATATRAK in a marketplace where eClinical efficiency is compromised by integration. The DATATRAK ONE™ unified product suite includes the following products, all built on a single database:
- uCTMS - unified Clinical Trial Management System
- uDesign - unified Trial Design
- uEDC - unified Electronic Data Collection
- uIRT - unified Interactive Response Technology
- uSafety - unified Safety Submission
- uTrain - unified Training Program
- uCDR - unified Clinical Data Repository
"Because DATATRAK ONE™'s products are unified and work seamlessly together, there is no need to make complex data connections. Our unique design gives our clients an advantage in the marketplace in terms of cost, timelines and ease-of-use," stated Chris Wilke, DATATRAK's Chief Technology Officer. "In providing a simple, easy-to-use product suite, the DATATRAK ONE™ solution safely accelerates drug programs from concept to cure™."
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK unified software suite, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market announcing its results for the three-month period ending March 31, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
Share this article